Literature DB >> 31590996

Propofol Reduces Inflammatory Brain Injury after Subarachnoid Hemorrhage: Involvement of PI3K/Akt Pathway.

Hua-Bin Zhang1, Xian-Kun Tu2, Quan Chen1, Song-Sheng Shi1.   

Abstract

BACKGROUND: Our previous study showed that propofol, one of the widely used anesthetic agents, can attenuate subarachnoid hemorrhage (SAH)-induced early brain injury (EBI) via inhibiting inflammatory and oxidative reaction. However, it is perplexing whether propofol attenuates inflammatory and oxidative reaction through modulating PI3K/Akt pathway. The present study investigated whether PI3K/Akt pathway is involved in propofol's anti-inflammation, antioxidation, and neuroprotection against SAH-induced EBI.
MATERIALS AND METHODS: Adult Sprague-Dawley rats underwent SAH and received treatment with propofol or vehicle after 2 and 12 hours of SAH. LY294002 was injected intracerebroventricularly to selectively inhibit PI3K/Akt signaling. Mortality, SAH grading, neurological scores, brain water content, evans blue extravasation, myeloperoxidase, malondialdehyde, superoxide dismutase, and glutathione peroxidase were measured 24 hours after SAH. Immunoreactivity of p-Akt, t-Akt, nuclear factor- kappa B (NF-κB) p65, nuclear factor erythroid-related factor 2 (Nrf2), NAD(P)H:quinone oxidoreductase (NQO1), and cyclooxygenase-2 (COX-2) in rat brain was determined by western blot. Tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in rat brain were examined by ELISA.
RESULTS: Propofol significantly reduces neurological dysfunction, BBB permeability, brain edema, inflammation, and oxidative stress, all of which were reversed by LY294002. Propofol significantly upregulates the immunoreactivity of p-Akt, Nrf2, and NQO1, all of which were abolished by LY294002. Propofol significantly downregulates the overexpression of NF-κB p65, COX-2, TNF-α, and IL-1β, all of which were inhibited by LY294002.
CONCLUSION: These results suggest that propofol attenuates SAH-induced EBI by inhibiting inflammatory reaction and oxidative stress, which might be associated with the activation of PI3K/Akt signaling pathway.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PI3K/Akt; Subarachnoid hemorrhage; early brain injury; inflammation; oxidative stress; propofol

Year:  2019        PMID: 31590996     DOI: 10.1016/j.jstrokecerebrovasdis.2019.104375

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  16 in total

1.  Neuroprotective Effect of Chrysophanol as a PI3K/AKT/mTOR Signaling Inhibitor in an Experimental Model of Autologous Blood-induced Intracerebral Hemorrhage.

Authors:  Kuldeep Singh Jadaun; Sidharth Mehan; Aarti Sharma; Ehraz Mehmood Siddiqui; Sumit Kumar; Naif Alsuhaymi
Journal:  Curr Med Sci       Date:  2022-01-26

Review 2.  A Systematic Review of Inflammatory Cytokine Changes Following Aneurysmal Subarachnoid Hemorrhage in Animal Models and Humans.

Authors:  Patrick Devlin; Tauheed Ishrat; Ansley Grimes Stanfill
Journal:  Transl Stroke Res       Date:  2022-03-09       Impact factor: 6.829

3.  Neuroprotective Effect of Chrysophanol as a PI3K/AKT/mTOR Signaling Inhibitor in an Experimental Model of Autologous Blood-induced Intracerebral Hemorrhage.

Authors:  Kuldeep Singh Jadaun; Sidharth Mehan; Aarti Sharma; Ehraz Mehmood Siddiqui; Sumit Kumar; Naif Alsuhaymi
Journal:  Curr Med Sci       Date:  2022-01-28

4.  Inhalational Versus Intravenous Anesthetic Conditioning for Subarachnoid Hemorrhage-Induced Delayed Cerebral Ischemia.

Authors:  Umeshkumar Athiraman; Abhijit V Lele; Menelaos Karanikolas; Vasu Babu Dhulipala; Keshav Jayaraman; Christine Fong; Rainer Kentner; Ravitha Sheolal; Ananth Vellimana; Jeffrey M Gidday; Rajat Dhar; Gregory J Zipfel
Journal:  Stroke       Date:  2021-11-04       Impact factor: 7.914

Review 5.  Emerging therapeutic targets for cerebral edema.

Authors:  Ruchira M Jha; Sudhanshu P Raikwar; Sandra Mihaljevic; Amanda M Casabella; Joshua S Catapano; Anupama Rani; Shashvat Desai; Volodymyr Gerzanich; J Marc Simard
Journal:  Expert Opin Ther Targets       Date:  2022-01-02       Impact factor: 6.797

6.  Protective Effects of Propofol on Rats with Cerebral Ischemia-Reperfusion Injury Via the PI3K/Akt Pathway.

Authors:  Yaru Chen; Zhenzhou Li
Journal:  J Mol Neurosci       Date:  2020-09-28       Impact factor: 3.444

7.  Neutrophil Extracellular Traps may be a Potential Target for Treating Early Brain Injury in Subarachnoid Hemorrhage.

Authors:  Hanhai Zeng; Xiongjie Fu; Jing Cai; Chenjun Sun; Mengyan Yu; Yucong Peng; Jianfeng Zhuang; Jingyin Chen; Huaijun Chen; Qian Yu; Chaoran Xu; Hang Zhou; Yang Cao; Libin Hu; Jianru Li; Shenglong Cao; Chi Gu; Feng Yan; Gao Chen
Journal:  Transl Stroke Res       Date:  2021-04-14       Impact factor: 6.829

Review 8.  Implications of Phosphoinositide 3-Kinase-Akt (PI3K-Akt) Pathway in the Pathogenesis of Alzheimer's Disease.

Authors:  Manish Kumar; Nitin Bansal
Journal:  Mol Neurobiol       Date:  2021-10-26       Impact factor: 5.682

9.  Calpain-2 plays a pivotal role in the inhibitory effects of propofol against TNF-α-induced autophagy in mouse hippocampal neurons.

Authors:  Ying Li; Zhiyong He; Hu Lv; Wei Chen; Jiawei Chen
Journal:  J Cell Mol Med       Date:  2020-07-06       Impact factor: 5.310

Review 10.  Role of Anesthetics and Their Adjuvants in Neurovascular Protection in Secondary Brain Injury after Aneurysmal Subarachnoid Hemorrhage.

Authors:  Umeshkumar Athiraman; Gregory J Zipfel
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.